50
Participants
Start Date
December 31, 2016
Primary Completion Date
March 31, 2019
Study Completion Date
May 16, 2019
Pneumovax 23
All participants will receive a single 0.5 mL Pneumovax 23 intramuscular vaccine at baseline.
Blood tests
All participants will have two 50 milliliter blood draws: at baseline and up to 6 weeks later.
Questionnaires
"All participants will answer the following questionnaires:~UCLA Loneliness Scale Questionnaire will be used to measure a difference between the groups.~Perceived Stress Scale-10 Questionnaire will be used to measure a difference between the groups.~Interpersonal Support Evaluation List-12 will be used to measure a difference between the groups Life Orientation Test-Revised will be used to measure a difference between the groups."
Uf Ctsi Crc, Gainesville
University of Florida
OTHER